#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
9	15824434	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2667;groupNumber4
17	12247910	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0822;groupNumber5
11	54935103	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3864;groupNumber9
11	54935575	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.275;groupNumber9
11	62250126	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3276;groupNumber11
11	67458793	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4222;groupNumber14
11	67458921	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.54;groupNumber14
11	96614289	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4567;groupNumber17
12	87132804	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.4828;groupNumber22
12	87132806	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber22
19	3594895	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4091;groupNumber38
19	3594993	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.6923;groupNumber38
19	3992845	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.2105;groupNumber40
19	3993091	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4333;groupNumber40
19	55506121	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.1316;groupNumber41
19	55506123	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2703;groupNumber41
X	16606097	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4416;groupNumber47
X	102564500	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.5294;groupNumber53
X	102564620	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.381;groupNumber53
X	102566321	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3704;groupNumber53
X	123796259	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.5;groupNumber54
X	123796323	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.3529;groupNumber54
3	34123377	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.2449;groupNumber57
3	34123447	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.875;groupNumber57
4	43642690	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4167;groupNumber62
4	43642703	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.2045;groupNumber62
4	142451839	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4737;groupNumber71
4	142451958	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.8654;groupNumber71
6	307725	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.05;groupNumber75
6	64956442	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2203;groupNumber83
1	150229920	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.2376;groupNumber99
22	29909005	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3125;groupNumber104
22	29909038	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.6136;groupNumber104
2	62539144	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.28;groupNumber108
2	115957531	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.2581;groupNumber110
2	115957841	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4667;groupNumber110
2	214745950	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.7324;groupNumber114
2	214746129	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.093;groupNumber114
7	67546958	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2642;groupNumber118
7	67547199	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1304;groupNumber118
7	99289669	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.5169;groupNumber122
7	99289744	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2727;groupNumber122
7	155180253	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.5185;groupNumber124
7	155180385	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4038;groupNumber124
10	27643688	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.4615;groupNumber133
10	27643746	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2759;groupNumber133
